News
A promising new cancer technology from NIH could help improve how liver cancer is diagnosed and treated. Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the deadliest cancers worldwide, and better treatment options are urgently needed. NIH inventors have developed two fully
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
Register to attend a free NIH webinar on Wednesday January 28, 2026 at 11am ET. Attendees will learn about a new AI enhanced real-time echocardiography device and method to improve the analysis and quantification of heart related conditions, by automatically extracting predictive biomarkers from an
Two National Institutes of Health (NIH) inventors, Drs. Steven Rosenberg and John O’Shea, have been selected as part of the 2025 National Academy of Inventors (NAI) Fellows. NAI Fellowship is the highest professional distinction awarded solely to inventors. The National Academy of Inventors is a